EP3320909A4 - Pharmaceutical composition that promotes capillary regeneration - Google Patents

Pharmaceutical composition that promotes capillary regeneration Download PDF

Info

Publication number
EP3320909A4
EP3320909A4 EP15897610.0A EP15897610A EP3320909A4 EP 3320909 A4 EP3320909 A4 EP 3320909A4 EP 15897610 A EP15897610 A EP 15897610A EP 3320909 A4 EP3320909 A4 EP 3320909A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical composition
promotes capillary
capillary regeneration
regeneration
promotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15897610.0A
Other languages
German (de)
French (fr)
Other versions
EP3320909A1 (en
Inventor
Eduardo ARIZA ANDRADE
Carlos Eduardo CHACÓN LÓPEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armesso Am Espana SL
Original Assignee
Armesso Am Espana SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armesso Am Espana SL filed Critical Armesso Am Espana SL
Publication of EP3320909A1 publication Critical patent/EP3320909A1/en
Publication of EP3320909A4 publication Critical patent/EP3320909A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
EP15897610.0A 2015-07-08 2015-07-08 Pharmaceutical composition that promotes capillary regeneration Pending EP3320909A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2015/070530 WO2017005942A1 (en) 2015-07-08 2015-07-08 Pharmaceutical composition that promotes capillary regeneration

Publications (2)

Publication Number Publication Date
EP3320909A1 EP3320909A1 (en) 2018-05-16
EP3320909A4 true EP3320909A4 (en) 2019-03-13

Family

ID=57684968

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15897610.0A Pending EP3320909A4 (en) 2015-07-08 2015-07-08 Pharmaceutical composition that promotes capillary regeneration

Country Status (3)

Country Link
EP (1) EP3320909A4 (en)
MX (1) MX2018000113A (en)
WO (1) WO2017005942A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028257A1 (en) * 2000-02-18 2002-03-07 Chris Catalfo Compositions and methods for treating baldness
US20070110731A1 (en) * 2005-11-16 2007-05-17 Riley Patricia A Integument Cell Regeneration Formulation
GB2481712A (en) * 2010-06-30 2012-01-04 Pangaea Lab Ltd Composition including ciclopirox olamine and VEGF for treating hair loss
CO6640053A1 (en) * 2011-09-30 2013-03-22 Amd Hair S A Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients
WO2013167927A1 (en) * 2012-05-11 2013-11-14 Biologix Hair Science Ltd. Formulation and method for treating hair loss

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028257A1 (en) * 2000-02-18 2002-03-07 Chris Catalfo Compositions and methods for treating baldness
US20070110731A1 (en) * 2005-11-16 2007-05-17 Riley Patricia A Integument Cell Regeneration Formulation
GB2481712A (en) * 2010-06-30 2012-01-04 Pangaea Lab Ltd Composition including ciclopirox olamine and VEGF for treating hair loss
CO6640053A1 (en) * 2011-09-30 2013-03-22 Amd Hair S A Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients
WO2013167927A1 (en) * 2012-05-11 2013-11-14 Biologix Hair Science Ltd. Formulation and method for treating hair loss

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EPODOC [online] EUROPEAN PATENT OFFICE, THE HAGUE, NL; 22 March 2013 (2013-03-22), "Composiciones farmacéuticas para el tratamiento de la alopecia, basadas en la combinación de concentraciones alopaticas y diluciones homeopaticas de principios activos", XP002788391, Database accession no. CO-11128862-A *
See also references of WO2017005942A1 *

Also Published As

Publication number Publication date
EP3320909A1 (en) 2018-05-16
MX2018000113A (en) 2018-09-18
WO2017005942A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
EP3339331A4 (en) Composition
EP3398996A4 (en) Composition
EP3248475A4 (en) Composition
SI3278801T1 (en) Pharmaceutical composition containing mirabegron
EP3275452A4 (en) Pharmaceutical composition containing silibinin
EP3246047A4 (en) Combination drug
EP3141243A4 (en) Pharmaceutical composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
EP3369418A4 (en) Composition
GB201521462D0 (en) Pharmaceutical composition
EP3524250A4 (en) Pharmaceutical composition
EP3378585A4 (en) Bonding composition
EP3366730A4 (en) Water-based-ink composition
HK1250491A1 (en) Stabilized pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
EP3244895A4 (en) Novel pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
EP3243510A4 (en) Sulfonamide pharmaceutical composition
EP3315031A4 (en) Composition
EP3274089A4 (en) Presulfurized catalyst composition
EP3170512A4 (en) Pharmaceutical composition
EP3466430A4 (en) Pharmaceutical composition
PL3424500T3 (en) Pharmaceutical composition comprising famitinib
EP3323837A4 (en) Composition
EP3322295A4 (en) Composition

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/23 20060101ALI20190122BHEP

Ipc: A61K 31/522 20060101ALI20190122BHEP

Ipc: A61K 38/08 20190101ALI20190122BHEP

Ipc: A61P 17/14 20060101ALI20190122BHEP

Ipc: A61K 38/18 20060101ALI20190122BHEP

Ipc: A61K 36/889 20060101AFI20190122BHEP

Ipc: A61K 36/87 20060101ALI20190122BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190211

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/889 20060101AFI20190201BHEP

Ipc: A61K 36/87 20060101ALI20190201BHEP

Ipc: A61P 17/14 20060101ALI20190201BHEP

Ipc: A61K 38/18 20060101ALI20190201BHEP

Ipc: A61K 36/23 20060101ALI20190201BHEP

Ipc: A61K 38/08 20190101ALI20190201BHEP

Ipc: A61K 31/522 20060101ALI20190201BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220614